QuidelOrtho To Report First Quarter 2024 Financial Results
17 Aprile 2024 - 1:00PM
Business Wire
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or
“QuidelOrtho”), a global provider of innovative in vitro diagnostic
technologies designed for point-of-care settings, clinical labs and
transfusion medicine, announced today it will report its financial
results for its first quarter ended March 31, 2024, after the
market close on Wednesday, May 8, 2024.
Following the release of financial results, QuidelOrtho will
hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to
discuss its financial results. Interested parties can access the
call on the “Events & Presentations” section of the “Investor
Relations” page of the Company’s website at
https://ir.quidelortho.com/. Presentation materials will also be
posted to the “Events & Presentations” section of the “Investor
Relations” page of the Company’s website at the time of the call.
Those unable to access the webcast may join the call via phone by
dialing 833-470-1428 (domestic) or +1 929-526-1599 (international)
and entering Conference ID number 295379.
A replay of the conference call will be available shortly after
the event on the “Investor Relations” page of the Company’s website
under the “Events & Presentations” section.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in
vitro diagnostics, developing and manufacturing intelligent
solutions that transform data into understanding and action for
more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular
testing, clinical chemistry and transfusion medicine, bringing
fast, accurate and reliable diagnostics when and where they are
needed – from home to hospital, lab to clinic. So that patients,
clinicians and health officials can spot trends sooner, respond
quicker and chart the course ahead with accuracy and
confidence.
Building upon its many years of groundbreaking innovation,
QuidelOrtho continues to partner with customers across the
healthcare continuum and around the globe to forge a new diagnostic
frontier. One where insights and solutions know no bounds,
expertise seamlessly connects and a more informed path is
illuminated for each of us.
QuidelOrtho is advancing diagnostics to power a healthier
future.
For more information, please visit www.quidelortho.com.
Source: QuidelOrtho Corporation
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240417178380/en/
Investor Contact: Juliet Cunningham Vice President,
Investor Relations IR@QuidelOrtho.com
Media Contact: D. Nikki Wheeler Senior Director,
Corporate Communications media@QuidelOrtho.com
Grafico Azioni QuidelOrtho (NASDAQ:QDEL)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni QuidelOrtho (NASDAQ:QDEL)
Storico
Da Mag 2023 a Mag 2024